Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Amortizatization of Intangibles (2019 - 2024)

Historic Amortizatization of Intangibles for Bioadaptives (BDPT) over the last 6 years, with Q2 2024 value amounting to $8387.0.

  • Bioadaptives' Amortizatization of Intangibles rose 113884.79% to $8387.0 in Q2 2024 from the same period last year, while for Mar 2025 it was $8387.0, marking a year-over-year decrease of 9235.89%. This contributed to the annual value of $52592.0 for FY2024, which is 5601.02% down from last year.
  • As of Q2 2024, Bioadaptives' Amortizatization of Intangibles stood at $8387.0, which was up 113884.79% from $44205.0 recorded in Q1 2024.
  • In the past 5 years, Bioadaptives' Amortizatization of Intangibles registered a high of $121360.0 during Q3 2020, and its lowest value of -$21049.0 during Q2 2020.
  • For the 5-year period, Bioadaptives' Amortizatization of Intangibles averaged around $39537.8, with its median value being $38274.5 (2020).
  • As far as peak fluctuations go, Bioadaptives' Amortizatization of Intangibles tumbled by 15371.15% in 2020, and later surged by 113884.79% in 2024.
  • Bioadaptives' Amortizatization of Intangibles (Quarter) stood at $38906.0 in 2020, then surged by 204.45% to $118450.0 in 2021, then tumbled by 34.18% to $77965.0 in 2022, then crashed by 65.07% to $27237.0 in 2023, then tumbled by 69.21% to $8387.0 in 2024.
  • Its last three reported values are $8387.0 in Q2 2024, $44205.0 for Q1 2024, and $27237.0 during Q4 2023.